GASTRIC CANCER (DIAGNOSIS)
Clinical trials for GASTRIC CANCER (DIAGNOSIS) explained in plain language.
Never miss a new study
Get alerted when new GASTRIC CANCER (DIAGNOSIS) trials appear
Sign up with your email to follow new studies for GASTRIC CANCER (DIAGNOSIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to tackle stomach cancer relapse
Disease control Not yet recruitingThis phase 2 trial tests a combination of three drugs—sintilimab, ramucirumab, and paclitaxel—in 30 adults with HER2-negative stomach cancer that came back during or within 6 months of finishing adjuvant therapy. The main goal is to see how many patients' tumors shrink significan…
Matched conditions: GASTRIC CANCER (DIAGNOSIS)
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Triple threat: new combo therapy targets Hard-to-Treat stomach cancer
Disease control Not yet recruitingThis clinical trial is testing a new approach for people with advanced HER2-negative stomach or gastroesophageal junction cancer that cannot be removed by surgery. The treatment combines two immunotherapy drugs (iparomlimab and tuvonralimab) with standard chemotherapy (SOX) and a…
Matched conditions: GASTRIC CANCER (DIAGNOSIS)
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Stomach fluid test could revolutionize gastric cancer diagnosis
Diagnosis Not yet recruitingThis study explores a new way to diagnose gastric cancer by analyzing tiny particles called extracellular vesicles found in stomach fluid. Researchers will collect stomach fluid from 100 patients undergoing gastroscopy and use a special sensor to detect cancer-related changes. Th…
Matched conditions: GASTRIC CANCER (DIAGNOSIS)
Sponsor: Beijing Friendship Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New app aims to ease recovery after cancer surgery
Symptom relief Not yet recruitingThis study tests a digital tool called RECapp that helps patients recover after surgery for esophageal or stomach cancer. The app lets patients track symptoms, get personalized self-care advice, and know when to contact their healthcare team. 250 adults in Sweden will use the app…
Matched conditions: GASTRIC CANCER (DIAGNOSIS)
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Remote exercise program aims to boost chemo completion in cancer patients
Symptom relief Not yet recruitingThis study tests whether a home-based exercise program can help people with gastrointestinal or lung cancer handle chemotherapy better. Up to 120 participants will be randomly assigned to either an aerobic and resistance exercise group or a stretching group. All activities are do…
Matched conditions: GASTRIC CANCER (DIAGNOSIS)
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Prehab and rehab: simple diet and exercise program aims to boost recovery in elderly stomach cancer patients
Symptom relief Not yet recruitingThis study tests a 'peri-habilitation' program for 30 gastric cancer patients aged 65 and older. Participants receive nutrition education and protein-enriched soy milk for two weeks before surgery, plus exercise training and continued nutrition support for three weeks after leavi…
Matched conditions: GASTRIC CANCER (DIAGNOSIS)
Phase: NA • Sponsor: Korea University Anam Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC